We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ZSB market cap is 8.59M. The company's latest EPS is CAD -0.0099 and P/E is -4.04.
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 135k | 106k | 268k | 672k | 35k |
| Operating Income | -3.16M | -3.4M | -1.76M | -2.42M | -1.7M |
| Net Income | -4.55M | -4.13M | -2.31M | -3.56M | -2.54M |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 4.26M | 2.14M | 1.29M | 1.29M | 1.03M |
| Total Liabilities | 2.07M | 2.09M | 1.38M | 1.08M | 3.54M |
| Total Equity | 2.19M | 48k | -97k | 215k | -2.51M |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.56M | -2.11M | -2.16M | -2.18M | -1.76M |
| Investing | N/A | -47k | N/A | N/A | N/A |
| Financing | 6.96M | -46k | 1.45M | 2.04M | 1.75M |
| Market Cap | 8.59M |
| Price to Earnings Ratio | -4.04 |
| Price to Sales Ratio | 400 |
| Price to Cash Ratio | 18.18 |
| Price to Book Ratio | -4.08 |
| Dividend Yield | - |
| Shares Outstanding | 256.45M |
| Average Volume (1 week) | 33.47k |
| Average Volume (1 Month) | 72.57k |
| 52 Week Change | -53.21% |
| 52 Week High | 0.0938 |
| 52 Week Low | 0.0305 |
| Spread (Intraday) | 0.01 (28.21%) |
| Company Name | Sirona Biochem Corp |
| Address |
wework - 595 burrard street vancouver, british columbia V7X 1L4 |
| Website | https://www.sironabiochem.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
